AP
KMTS

Andera Partners’s Kestra Medical Technologies KMTS Stock Holding History

Andera Partners’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.7M Buy
2,695,192
+155,086
+6% +$3.66M 30.36% 1
2025
Q4 		$67.4M Buy
+2,540,106
New +$65.4M 38.14% 1

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Andera Partners's KMTS Position: Q1 2026 in Review

Andera Partners increased its Kestra Medical Technologies (KMTS) stake by 6.1% in Q1 2026, buying an estimated $3.66M and bringing the position to 2,695,192 shares worth $53.7M. The position accounts for 30.36% of the portfolio, ranked #1.

Andera Partners first reported a position in KMTS in Q4 2025 and has held it in 2 quarters since. The position peaked at $67.4M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Andera Partners held 2,695,192 shares of Kestra Medical Technologies worth $53.7M as of Q1 2026.
  • Andera Partners bought 155,086 Kestra Medical Technologies shares in Q1 2026, an estimated $3.66M.
  • Kestra Medical Technologies made up 30.36% of Andera Partners's portfolio in Q1 2026, its #1 holding.
  • Andera Partners first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 2 quarters since.
  • Andera Partners's Kestra Medical Technologies position peaked at $67.4M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Andera Partners's 13F filing for Q1 2026, filed 11 May 2026.